Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice

International Immunology

Volumn 18, Issue 5, 2006, Pages 807-816

  Tjärnlund, Anna ^a   Rodríguez, Ariane ^a   Cardona, Pere Joan ^b   Guirado, Evelyn ^b   Ivanyi, Juraj ^c   Singh, Mahavir ^d   Troye Blomberg, Marita ^a   Fernández, Carmen ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Germans Trias i Pujol Foundation   (Spain)

^c GUY S HOSPITAL   (United Kingdom)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Mucosal immunity; Mycobacteria; plgR; Secretory IgA

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INDUCIBLE NITRIC OXIDE SYNTHASE; RANTES; SECRETORY COMPONENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVA ANALYSIS; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN A, SECRETORY; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE SYNTHASE TYPE II; RANTES; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; RESPIRATORY TRACT INFECTIONS; RNA, MESSENGER; SECRETORY COMPONENT; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646894153     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl017     Document Type: Article

References (61)

1. Mestecky, J. and Russel, M. W. 1997. Mucosal immunoglobulins and their contribution to defence mechanisms: An overview. Biochem. Soc. Trans. 25:457.
2. Mostov, K. E. 1994. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12:63.
3. Stokes, C. R., Soothill, J. F. and Turner, M. W. 1975. Immune exclusion is a function of IgA. Nature 255:745.
4. Mazanec, M. B., Kaetzel, C. S., Lamm, M. E., Fletcher, D. and Nedrud, J. G. 1992. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl Acad. Sci. USA 89:6901.
5. Ruggeri, F. M., Johansen, K., Basile, G., Kraehenbuhl, J. P. and Svensson, L. 1998. Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J. Virol. 72:2708.
6. Motegi, Y., Kita, H., Kato, M. and Morikawa, A. 2000. Role of secretory IgA, secretory component, and eosinophils in mucosal inflammation. Int. Arch. Allergy Immunol. 122(Suppl. 1):25.
7. Shen, L. and Collins, J. 1989. Monocyte superoxide secretion triggered by human IgA. Immunology 68:491.
8. Shen, L. and Fanger, M. W. 1981. Secretory IgA antibodies synergize with IgG in promoting ADCC by human polymorphonuclear cells, monocytes, and lymphocytes. Cell. Immunol. 59:75.
9. Raviglione, M. C., Snider, D. E., Jr, Kochi, A., Schaible, U. E., Collins, H. L. and Kaufmann, S. H. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220.
10. Riley, R. L., Mills, C. C., Nyka, W. et al. 1995. Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. Am. J. Epidemiol. 142:3.
11. Gomes, M. S., Paul, S., Moreira, A. L., Appelberg, R., Rabinovitch, M. and Kaplan, G. 1999. Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun. 67:3199.
12. Malik, Z., Sifyer, A., Iyer, S. S. and Kusner, D. J. 2001. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: Contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J. Immunol. 166:3392.
13. Orme, I. M., Roberts, A. D., Griffin, J. P. and Abrams, J. S. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151:518.
14. Schaible, U. E., Collins, H. L. and Kaufmann, S. H. 1999. Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71:267.
15. Turner, J., Frank, A. A., Brooks, J. V., Gonzalez-Juarrero, M. and Orme, I. M. 2001. The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp. Gerontol. 36:537.
16. Vordermeier, H. M., Venkataprasad, N., Harris, D. P. and Ivanyi, J. 1996. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 106:312.
17. Glatman-Freedman, A. 2003. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: Implications for a novel vaccine strategy. FEMS Immunol. Med. Microbiol. 39:9.
18. Edelson, B. T. and Unanue, E. R. 2001. Intracellular antibody neutralizes Listeria growth. Immunity 14:503.
19. Winslow, G. M., Yager, E., Shilo, K., Volk, E., Reilly, A. and Chu, F. K. 2000. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect. Immun. 68:2187.
20. Rodriguez, A., Troye-Blomberg, M., Lindroth, K., Ivanyi, J., Singh, M. and Fernandez, C. 2003. B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization. Vaccine 21:458.
21. Falero-Diaz, G., Challacombe, S., Banerjee, D., Douce, G., Boyd, A. and Ivanyi, J. 2000. Intranasal vaccination of mice against infection with Mycobacterium tuberculosis. Vaccine 18:3223.
22. Williams, A., Reljic, R., Naylor, I. et al. 2004. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 111:328.
23. Rodriguez, A., Tjärnlund, A., Ivanyi, J. etal. 2005. Role of IgA in the defense against respiratory infections: IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG. Vaccine 23:2565.
24. Lyadova, I. V., Vordermeier, H. M., Eruslanov, E. B., Khaidukov, S. V., Apt, A. S. and Hewinson, R. B. 2001. Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs. Clin. Exp. Immunol. 126:274.
25. Asahi, Y., Yoshikawa, T., Watanabe, I. et al. 2002. Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines. J. Immunol. 168:2930.
26. Shimada, S., Kawaguchi-Miyashita, M., Kushiro, A. et al. 1999. Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J. Immunol. 163:5367.
27. Cardona, P. J., Gordillo, S., Diaz, J. et al. 2003. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/ 6 mice to experimental aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 71:5845.
28. James, B. W., Williams, A. and Marsh, P. D. 2000. The physiology and pathogenicity of Mycobacterium tuberculosis grown under controlled conditions in a defined medium. J. Appl. Microbiol. 88:669.
29. Mustafa, T., Phyu, S., Nilsen, R., Jonsson, R. and Bjune, G. 1999. A mouse model for slowly progressive primary tuberculosis. Scand. J. Immunol. 50:127.
30. Flesch, I. E. and Kaufmann, S. H. 1990. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675.
31. Bean, A. G., Roach, D. R., Briscoe, H. et al. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504.
32. Flynn, J. L., Goldstein, M. M., Chan, J. et al. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561.
33. Mohan, V. P., Scanga, C. A., Yu, K., Scott, H. M., Tanaka, K. E. and Tsang, E. 2001. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology. Infect. Immun. 69:1847.
34. Chensue, S. W., Warmington, K. S., Allenspach, E. J. et al. 1999. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J. Immunol. 163:165.
35. Dairaghi, D. J., Soo, K. S., Oldham, E. R. et al. 1998. RANTES-induced T cell activation correlates with CD3 expression. J. Immunol. 160:426.
36. Taub, D. D., Turcovski-Corrales, S. M., Key, M. L., Longo, D. L. and Murphy, W. J. 1996. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095.
37. van Egmond, M., Damen, C. A., van Spriel, A. B., Vidarsson, G., van Garderen, E. and van de Winkel, J. G. 2001. IgA and the IgA Fc receptor. Trends Immunol. 22:205.
38. Rodriguez, A., Rottenberg, M., Tjärnlund, A. and Fernandez, C. 2006. Immunoglobulin A and CD8+ T-cell mucosal immune defences protect against intranasal infection with Chlamydia pneumoniae. Scand. J. Immunol. 63:177.
39. Johansen, F. E., Pekna, M., Norderhaug, I. N. et al. 1999. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 190:915.
40. Uren, T. K., Johansen, F. E., Wijburg, O. L., Koentgen, F., Brandtzaeg, P. and Strugnell, R. A. 2003. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170:2531.
41. Kim, K. J. and Malik, A. B. 2003. Protein transport across the lung epithelial barrier. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L247.
42. Gerritsen, J. 2000. Host defence mechanisms of the respiratory system. Paediatr. Respir. Rev. 1:128.
43. Boren, T., Falk, P., Roth, K. A., Larson, G. and Normark, S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262:1892.
44. Crottet, P. and Corthesy, B. 1998. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: A possible implication for mucosal defense. J. Immunol. 161:5445.
45. Dallas, S. D. and Rolfe, R. D. 1998. Binding of Clostridium difficile toxin A to human milk secretory component. J. Med. Microbiol. 47:879.
46. Ma, J. K., Hikmat, B. Y., Wycoff, K. et al. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4:601.
47. Marshall, L. J., Perks, B., Rekol, T. and Shute, J. K. 2001. IL-8 released constitutively by primary bronchial epithelial cells in culture forms inactivate complex with secretory component. J. Immunol. 167:2816.
48. Phalipon, A., Cardona, A., Kraehenbuhl, J. P., Edelman, L., Sansonetti, P. J. and Corthesy, B. 2002. Secretory component: A new role in secretory IgA-mediated immune exclusion in vivo. Immunity 17:107.
49. van Spriel, A. B., Leusen, J. H., Vile, H. and van de Winkel, J. G. 2002. Mac-1 (CD11b/CD18) as accessory molecule for Fc alpha R (CD89) binding of IgA. J. Immunol. 169:3831.
50. Wold, A. E, Mestecky, J., Tomana, M. et al. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect. Immun. 58:3073.
51. Schroten, H., Stapper, C., Plogmann, R., Köhler, H., Hacker, J. and Hanisch, F.-G. 1998. Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides. Infect. Immun. 66:3971.
52. Biesbrock, A. R., Reddy, M. S. and Levine, M. J. 1991. Interaction of salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect. Immun. 59:3492.
53. Magnusson, K. E. and Stjernström, I. 1982. Mucosal barrier mechanisms. Interplay between secretory IgA (SIgA), IgA and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology 45:239.
54. Asahi-Ozaki, Y., Yoshikawa, T., Iwakura, Y. et al. 2004. Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus. J. Med. Virol. 74:328.
55. Favre, L., Spertini, F. and Corthésy, B. 2005. Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J. Immunol. 175:2793.
56. Quan, C. P., Berneman, A., Pires, R., Avrameas, S. and Bouvet, J.-P. 1997. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect. Immun. 65:3997.
57. Chan, E. D., Chan, J. and Schluger, N. W. 2001. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am. J. Respir. Cell Mol. Biol. 25:606.
58. Cerretti, D. P., Nelson, N., Kozlosky, C. J. et al. 1993. The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics 18:410.
59. Becker, M. D., O'Rourke, L. M., Blackman, W. S., Planck, S. R. and Rosenbaum, J. T. 2000. Reduced leukocyte migration, but normal rolling and arrest, in interleukin-8 receptor homologue knockout mice. Invest. Ophthalmol. Vis. Sci. 41:1812.
60. Hang, L., Frendeus, B., Godaly, G. and Svanborg, C. 2000. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J. Infect. Dis. 182:1738.
61. Lee, J., Cacalano, G., Camerato, T., Toy, K., Moore, M. W. and Wood, W. I. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155:2158.